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OBJECTIVE. In November 2009, routine sampling of endoscopes performed to monitor the effectiveness of the endoscope-cleaning 
procedure at our hospital detected Pseudomonas aeruginosa. Herein we report the results of the subsequent investigation. 
DESIGN AND METHODS. The investigation included environmental cultures for source investigation, molecular analysis by pulsed-field 
gel electrophoresis (PFGE) to reveal the identity of the strains, and determination of the bactericidal activity of the glutaraldehyde-based 
disinfectant used for automated endoscope reprocessing. In addition, patient outcome was analyzed by medical chart review, and incidence 
rates of clinical samples with P. aeruginosa were compared. 
SETTING. The University Hospital of Basel is an 855-bed tertiary care center in Basel, Switzerland. Approximately 1,700 flexible bron-
choscopic, 2,500 gastroscopic, 1,400 colonoscopic, 140 endoscopic retrograde cholangiopancreatographic, and 140 endosonographic pro-
cedures are performed annually. 
RESULTS. P. aeruginosa was detected in samples obtained from endoscopes in November 2009 for the first time since the initiation of 
surveillance in 2006. It was found in the rinsing water and in the drain of 1 of the 2 automated endoscope reprocessors. PFGE revealed 
2 distinct P. aeruginosa strains, one in each reprocessor. The glutaraldehyde-based disinfectant showed no activity against the 2 pseudo-
outbreak strains when used in the recommended concentration under standard conditions. After medical chart review, 6 patients with 
lower respiratory tract and bloodstream infections were identified as having a possible epidemiological link to the pseudo-outbreak strain. 
CONCLUSIONS. This is the first description of a pseudo-outbreak caused by P. aeruginosa with reduced susceptibility to an aldehyde-
based disinfectant routinely used in the automated processing of endoscopes. 
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Since its introduction in the 1960s, flexible endoscopy has rods and Mycobacterium species. Pseudomonas aeruginosa is 
become standard of care for many indications in which open the organism that is most commonly detected in gastroin-
surgery is mandatory. Approximately 500,000 bronchoscopic testinal endoscopy-associated and bronchoscopy-associated 
examinations and 10 million gastrointestinal endoscopic ex- outbreaks.5 
aminations are performed in the United States annually.1
 F a i l u r e t o f o l l o w recommended cleaning and disinfection 
Despite the large number of endoscopic examinations per-
 p r o c e d u r e s p r o bably constitutes the single most important 
formed, hospital-acquired infections attributable to flexible
 f a c t 0 f k a d i n g t Q e n d o s c o p i c t r a n s m i s s i o n o f microorganisms 
endoscopy are rare. The American Society of Gastrointestinal , • ., .
 r ., , 6 „, , 
„ ,
 r
' . , , . , . , . . . _ ., and is the most common cause of outbreaks. There have 
been a few notable exceptions in which problems related to 
Endoscopy estimated the risk as approximately 1 in 1.8 mil-
lion gastrointestinal procedures.2 The actual transmission of , , , , , , , . . . . 
. c 4.- • J • J • • *• u the endoscopes themselves have lead to contamination despite 
infectious organisms during endoscopic examination, how- r
 7» 
ever, may go unrecognized because of inadequate surveillance t h e u s e o f a n a d e ( J u a t e rePr°cessing technique. -8 
and the lack of formal, prospective surveillance data, which I n November 2009, the results of routine sampling of 
can lead to unrecognized or unreported outbreaks.3 Although endoscopes showed growth of P. aeruginosa. Such microbi-
such outbreaks are relatively uncommon, endoscopes are the ological surveillance is performed twice yearly and was ini-
most frequent cause of outbreaks of device-related hospital- tiated 1999 to monitor the performance of the endoscope 
acquired infection.4 Most of the outbreaks related to endo- reprocessor. Herein we report the results of the subsequent 
scopes involved waterborne organisms, such as gram-negative pseudo-outbreak investigation. 
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METHODS 
Setting 
The University Hospital of Basel is an 855-bed tertiary care 
center in Basel, Switzerland. Approximately 1,700 flexible 
bronchoscopic, 2,500 gastroscopic, 1,400 colonoscopic, 140 
endoscopic retrograde cholangiopancreatographic, and 140 
endosonographic procedures are performed annually. A large 
majority of bronchoscopic examinations include bronchoal-
veolar lavage, in which sterile saline is instilled into the lower 
airways and then aspirated to obtain specimens. Biopsies are 
performed in most of the other endoscopic procedures. 
Endoscope Cleaning Procedures 
Endoscopes used for gastrointestinal and bronchoscopic pro-
cedures are cleaned by trained personnel in accordance with 
national guidelines9 and the manufacturer's recommenda-
tions (Olympus and Pentax). After use, the instrument's outer 
surface is wiped to avoid surface drying. Endoscopes are then 
immediately soaked in cleaner and disinfectant solution (Sek-
usept aktiv) based on peracetic acid. Thereafter, they are 
cleaned manually by wiping the outer surface and brushing 
the inner channels. Endoscopes then undergo high-level 
disinfection in an automated endoscope washer disinfector 
(Hamo Endoclean 2000; Steris) in which glutaraldehyde and 
glyoxal (3.5 g and 6.0 g per 100 g, respectively; neodisher 
Septo V459) are used as liquid disinfectant. According to the 
manufacturer's recommendation, the disinfectant was used 
at a working concentration of 1% at a temperature of 
50°C-60°C for 5-10 min. Finally, the channels are dried with 
pressurized air. Logbooks are used to record when water filters 
and solutions are changed in the reprocessors. 
Surveillance 
As part of the quality assurance program to monitor the 
effectiveness of the endoscope cleaning procedure, endo-
scopes were routinely sampled twice yearly. 
Reinforced Cleaning Procedures 
From January through February 2010, after detection of the 
pseudo-outbreak of P. aeruginosa infection, the disinfectant 
used for high-level disinfection in the automated endoscope 
reprocessor was changed to Neodisher Septo DN 2 (20 g of 
glutaraldehyde per 100 g of disinfectant). According to the 
manufacturer's recommendation, the disinfectant was used 
at a working concentration of 1% at a temperature of 50-55°C 
for 5 min. In addition, a rinse aid (Neodisher mediklar) was 
added to the automated cleaning procedure, and thermal dis-
infection of the automated endoscope reprocessor was per-
formed 3 times weekly by running the processor while empty 
at 90°C for 10 min. 
From March 2010, the concentration of the disinfectant 
Neodisher Septo DN 2 was increased to 2% and the appli-
cation time was increased to 10 min. In addition, the auto-
mated endoscope reprocessors were run while empty once a 
week with the detergent Neodisher SeptoClean (consisting of 
<5% nonionic surfactants, amphoteric surfactants, and 
15%—30% phosphates), and thermal disinfection was reduced 
to once weekly. 
Reinforced Surveillance 
After introduction of the reinforced cleaning procedures, sur-
veillance was intensified by sampling the rinsing water from 
the automated reprocessors twice weekly and sampling en-
doscopes twice monthly. 
Microbiological Methods 
Routine sampling of endoscopes was performed by injecting 
20 mL of sterile saline solution (NaCl 0.9%) into each air/ 
water and suction/biopsy channel according to recommen-
dations outlined by the Robert Koch Institute.10 The volumes 
of solution injected were recovered at the distal end of the 
endoscope. The number of viable bacteria in the samples 
collected was determined by conventional culture after 
inoculation on blood agar and filtration on 0.45 jttm 
membrane filters. After 72 hours of incubation at 359C, the 
number of colony-forming units (CFUs) was counted, and 
the results were expressed as the number of viable micro-
organisms. Subcultures were performed for identification. 
During the pseudo-outbreak investigation, swab samples 
from the interior of the automated endoscope reprocessor 
(Hamo Endoclean 2000; Steris), along with samples of clean-
ing solutions and of solutions and water used in the auto-
mated endoscope reprocessors, were sent for bacterial culture. 
Furthermore, swab samples were taken from all supplying 
water pipes. The water filters of the automated endoscope 
reprocessors were exchanged and were also cultured. 
Surface samples were obtained with the use of sterile mois-
tened cotton swabs. Bacterial cultures of the used rinsing 
water, obtained direcdy from the automated endoscope re-
processors, were performed once to twice weekly. Further-
more, routine sampling of endoscopes was performed at least 
weekly. 
The bactericidal activity was determined using the standard 
method for testing the bactericidal activity of chemical dis-
infectants according to the German Society for Hygiene and 
Microbiology.11 The disinfectant Neodisher Septo DN 2 (glu-
tardialdehyde 20 g per 100 g) was tested for activity against 
the pseudo-outbreak isolate of P. aeruginosa and against the 
reference strain P. aeruginosa ATCC 15442. From 1.5 to 
5 x 109 CFU of the isolates were diluted to 10"5 CFU/mL, 
then 8 mL of the disinfectant were added and a quantitative 
suspension test with and without an organic load (0.2% al-
bumin) was performed. After exposure times of 5 and 10 
min, respectively, at 50°C, the disinfectant was inactivated 
and the suspension was cultured for 48 hours at 36°C. If a 
reduction factor of 5 in the number of CFU was achieved, 
the disinfectant was regarded as effective according to EN 
1040 (available at http://www.cen.eu). 
Molecular typing to determine the clonality and the trans-
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mission pattern of P. aeruginosa was performed by pulsed-
field gel electrophoresis (PFGE) as described elsewhere.12 
Interpretation of Endoscope Sampling Results 
Results were interpreted according to the guidelines of the 
Robert Koch Institute.10 The threshold value for the concen-
tration of CFU was less than or equal to 1 CFU/mL of re-
covery solution, and detection of any of the following bacteria 
was regarded as an indicator for insufficient disinfection, in-
dependent of the number of CFU: Enterobacteriaceae, 
Enterococci, Pseudomonas aeruginosa, other nonfermenting 
gram-negative bacteria, Staphylococcus aureus, and viridans 
streptococci. 
Patient Outcomes 
All patients who underwent endoscopic examination from 
April through November 2009 were identified from the en-
doscopy database and were retrospectively assessed for the 
presence of colonization or infection due to P. aeruginosa. If 
P. aeruginosa was detected in any sample after endoscopic 
examination, an epidemiological link was assessed by full 
chart review of 2 board-certified infectious diseases specialists. 
Transmission was regarded as possible if the strain detected 
in the clinical specimen revealed the same phenotypic features 
(ie, the same susceptibility test result) as the strain detected 
in the endoscopes and if prior colonization or infection of 
the patient with P. aeruginosa was not documented in either 
the medical records or in the computerized database of the 
microbiology laboratory or if prior colonization or infection 
with P. aeruginosa was present (as identified by medical chart 
review or documented in the database of the microbiology 
laboratory) but susceptibilty test results differed for at least 
2 of the following antibiotic classes: quinolones, aminogly-
cosides, carbapenems, cefepime, and piperacillin-tazbactam. 
Upper and lower respiratory tract and bloodstream infections 
were defined according to the criteria of the Centers for Dis-
ease Control and Prevention.13 From December 2009 through 
January 2010, all consecutive samples (specimens recovered 
from the respiratory tract or from tissue and blood cultures) 
with detection of P. aeruginosa from patients who had un-
dergone endoscopic examination within the previous 6 
months were prospectively collected and molecularly typed. 
Furthermore, incidence rates of the number of clinical 
samples with detection of P. aeruginosa were compared for 
the years 2009 and 2008. The number of patients who un-
derwent endoscopic examination within 30 days before de-
tection of P. aeruginosa in a respiratory tract or tissue sample 
or in blood cultures was compared for the years 2009 and 
2008. 
RESULTS 
Routine surveillance to monitor the effectiveness of the en-
doscope cleaning procedure detected P. aeruginosa in 23 
(32%) of 73 samples from a total of 40 endoscopes in No-
vember 2009. This pathogen had not been detected since the 
initiation of routine surveillance in 1999. In the following 
samples, obtained from endoscopes during the period from 
November 4 through December 7, 2009, P. aeruginosa was 
detected in 29 (29%) of 99 investigational samples. 
Endoscope Cleaning Procedures 
Endoscopic and reprocessing procedures were observed on-
site by an infection control practitioner and hospital epide-
miologist. No significant breaches in technique were noted, 
but several changes were noted during the last year before 
the pseudo-outbreak. Examination of the maintenance 
records for the automated endoscope reprocessors demon-
strated that the drying program had been reduced from 10 
min to 5 min to expedite turnaround time. In 
addition, the rinse aid was discontinued in July 2009 to di-
minish foaming. The microprocessor running the process was 
double-checked by a representative of the manufacturer, and 
the written protocol did not reveal any deviation from the 
normal procedure. However, a manual check identified failure 
of the reprocessor to reach the required target temperature, 
although only in very few of the monitored cycles. 
Sampling because of Pseudo-Outbreak Investigation 
A total of 103 environmental samples were taken from No-
vember through December 2009. P. aeruginosa could be de-
tected in the rinsing water as well as in the drain of 1 of the 
2 automated endoscope reprocessors (Table 1). However, the 
pathogen could not be detected in the supplying water pipes, 
filters, or ventilation shafts of the reprocessors, nor could it 
be detected in the hospital water supply tanks or in any of 
the cleaning solutions or disinfectants used for reprocessing 
the endoscopes. 
Molecular Typing 
PFGE revealed 2 distinct P. aeruginosa strains (A and B) re-
covered from the rinsing water of the 2 different automated 
endoscope reprocessors as well as from the drain of 1 of the 
reprocessors. One automated reprocessor was contaminated 
with strain A, whereas the other was contaminated with strain 
B. 
During the pseudo-outbreak, all strains from patients with 
P. aeruginosa infection who had undergone endoscopic ex-
amination within the previous 6 months were stored at 
— 70°C. These strains were detected from clinical samples 
submitted to the laboratory or were obtained by the infectious 
disease consultation service. Molecular typing of all consec-
utive patient samples (n = 18) in which P. aeruginosa was 
detected did not reveal a clone that matched one of the strains 
isolated from the automated reprocessors. 
Bactericidal Tests 
The disinfectant Neodisher Septo DN 2 (glutardialdehyde 20 
g per 100 g) was tested for activity against the pseudo-
outbreak isolate of P. aeruginosa and against the reference 
strain P. aeruginosa ATCC 15442. For the reference strain, a 
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TABLE i. Results of Cultures of Specimens 
Source and type of specimen 
Washers (automated endoscope reprocessors) 
Interior of washer (surface samples) 
Supplying waterpipes (surface samples) 
Filters 
Rinsing water 
Ventilation shaft 
Drains 
Water-supplying tanks of the hospital 
Water 
Disinfectant 
Cleaning solutions 
reduction factor greater than 5 log10 CFU was achieved when 
using concentrations of 0.5% to 2% for 5 min and 10 min 
at 20°C and 55°C. For the 2 pseudo-outbreak strains, a re-
duction factor greater than 5 could only be achieved when 
using 2% of the disinfectant for 10 min at 55°C (Table 2). 
At 20°C, bacterial growth could still be detected with a re-
duction factor of less than 5, which confirmed dramatically 
reduced bactericidal activity (Table 3). 
Reinforced Cleaning Procedures 
After introduction of the reinforced cleaning procedures, P. 
aeruginosa could no longer be detected in the samples ob-
tained from endoscopes. However, in the cultures of the rins-
ing water, which was checked twice weekly, P. aeruginosa 
reemerged at the beginning of March 2010. PFGE revealed 
identity to 1 of the 2 pseudo-outbreak strains (strain A). 
Cleaning procedures were changed as described above, on the 
basis of the bactericidal test results. After March 2010, P. 
aeruginosa was no longer detected in either the samples ob-
tained from the endoscopes or the rinsing water of the au-
tomated reprocessors. 
Patient Outcomes 
A total of 63 patients who underwent endoscopic examination 
from April through November 2009 had samples (obtained 
either from the respiratory tract or from tissue and blood 
cultures after endoscopy was performed) that revealed P. aeru-
ginosa. The epidemiologic investigations failed to identify a 
link in 20 of 63 patients. After medical chart review by 2 
infectious disease specialists, lower respiratory tract and 
bloodstream infections possibly caused by the pseudo-
outbreak strain were detected in 6 patients. 
The comparison of the number of patients who underwent 
endoscopic examination 30 days before detection of P. aeru-
ginosa in a respiratory tract or tissue sample or in blood 
cultures showed no increase, with 30 patients fitting this def-
inition in 2008 and 27 patients fitting this definition in 2009. 
The number of procedures performed was 5,544 in 2008 and 
5,630 in 2009, which accounted for 0.54% (30 of 5,544) and 
0.48% (27 of 5,630) of the patients with detection of P. aeru-
m Environmental Sources 
Pseudomonas aeruginosa isolated on culture 
No 
No 
No 
Yes 
No 
Yes 
No 
No 
No 
ginosa in a clinical specimen within 30 days after endoscopic 
examination. 
D I S C U S S I O N 
This is, to our knowledge, the first report of a pseudo-
outbreak caused by contamination of automated endoscope 
reprocessors with 2 different strains of P. aeruginosa resistant 
to aldehydes and heat. No increase in the incidence of in-
fection caused by this pathogen could be detected during the 
outbreak period. However, 6 patients could have potentially 
been infected by contaminated endoscopes. 
Glutaraldehyde has been used as a high-level disinfectant 
for approximately 30 years and displays potent bactericidal, 
fungicidal, mycobactericidal, sporicidal, and virucidal activity, 
which is based on its interaction with amino groups in pro-
teins and enzymes.14 Glutaraldehyde-resistant mycobacteria 
have been revealed as a source of recontamination of en-
doscopes and have been detected in endoscope washers, 
which has led to misdiagnosis of infections.15,16 Furthermore, 
these pathogens were found to be cross-resistant to peracetic 
acid.16 Nevertheless, an increase in the activity of glutaral-
dehyde could be obtained by increasing the temperature of 
the washer to 50°C.16 A strain of P. aeruginosa resistant to 
disinfection with glutaraldehyde was isolated from endo-
scopes and from tap water by Kovacs et al17 in 1998. However, 
glutaraldehyde was used at room temperature, and resistance 
testing was performed at 37°C. In contrast, tests revealed our 
pseudo-outbreak strains to be resistant even when using the 
recommended glutaraldehyde concentration of 1% at 55°C, 
and they survived thrice-weekly thermal disinfection at 90°C. 
Resistance to high-level disinfection with glutaraldehyde of 
P. aeruginosa has been reported in dental and medical de-
vices18 but was associated with the pathogen being entrapped 
in lubricants used in dental handpieces and endoscopes and 
with the disinfectant not being able to penetrate the lubricant. 
P. aeruginosa is a pathogen that is well known for its ability 
to adapt to changing environmental conditions. In chronic 
infection, this pathogen can survive attacks by the host im-
mune system and the action of antimicrobial substances by 
undergoing phenotypic and genetic adaptation, resulting in 
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TABLE 2. Bactericidal Tests with Glutaraldehyde (20 g/100 g)Applied for 10 Min at 55°C 
Strain, glutaraldehyde concentration, % Bacterial growth Reduction factor of no. of CFU 
Pseudomonas aeruginosa (strain A) 
0.5 
1.0 
2.0 
P. aeruginosa (strain B) 
0.5 
1.0 
2.0 
P. aeruginosa (ATCC 15442) 
0.5 
1.0 
2.0 
Yes 
Yes 
No 
Yes 
Yes 
No 
No 
No 
No 
<4.12 
>5.50 
>5.50 
<4.00 
4.42 
>5.39 
>5.55 
>5.55 
>5.55 
the progressive loss of virulence and the development of in-
creased persistence. However, the underlying strategies and 
mechanisms employed by P. aeruginosa are still relatively 
poorly understood.19 
The question arises whether resistance to disinfectants is 
attributable to primary resistance or to the development of 
resistance, similar to the development of resistance to anti-
biotics. In 1976, 5 fully susceptible laboratory strains were 
described that were exposed for longer periods of time to 
sublethal doses of 4 basic constituents of disinfectants (phe-
nole, isopropanole, formaldehyde, and chloramine 80). After 
multiple passages, an increase in resistance against formal-
dehyde and chloramine 80 could be noted.20 The organisms 
tested were Staphylococcus aureus, Escherichia coli, Aerobacter 
cloacae, P. aeruginosa, and Klebsiella pneumoniae. Spicher et 
al21 reported that strains of P. aeruginosa vary widely in their 
susceptibility to formaldehyde, with the need to use concen-
trations almost 3 times as high for the most resistant strain 
than for the most susceptible strain to obtain equal micro-
bicidal effects. 
Possible mechanisms of action could be enzymatic 
degradation and extracellular and intracellular penetration 
barriers. Formaldehyde degredation could be detected pho-
tometrically in P. aeruginosa strains. The highest formalde-
hyde resistance correlated with a formaldehyde dehydroge-
nase activity that was 100 times higher than that for a 
relatively susceptible ATCC strain.22 Interestingly, the tested 
strains exhibited markedly differing resistance to formalde-
hyde, with some environmental isolates growing even at con-
centrations in the range of commonly used disinfectant 
solutions. 
Our strains may have become resistant because of the use 
of glutaraldehyde at suboptimal application durations and 
possibly because of inadequate temperatures, because our au-
tomated reprocessors may not have consistently achieved a 
temperature of 55°C as a result of inconsistent failure of the 
microprocessors caused by wear. In addition, the rinse aid, 
which was discontinued, facilitates and accelerates the drying 
process, and the drying program had been reduced from 10 
min to 5 min; these changes may have contributed to the 
contamination of the endoscopes, especially because gram-
negative bacteria do not survive as long as gram-
positive bacteria on dry surfaces.23 
The susceptibility of P. aeruginosa to different chemical 
germicides was also tested by Sagripanti et al,24 which revealed 
that this pathogen, together with S. aureus, showed the most 
resistance.24 Less than 4 logs inactivation were observed after 
treatment with glutaraldehyde or hypochlorite of an ATCC 
TABLE 3. Bactericidal Tests with Glutaraldehyde (20 g/100 g) Applied for 10 Min at 20°C 
Strain, glutaraldehyde concentration, % Bacterial growth Reduction factor of no. of CFU 
Pseudomonas aeruginosa (strain A) 
0.5 
1.0 
2.0 
P. aeruginosa (strain B) 
0.5 
1.0 
2.0 
P. aeruginosa (ATCC 15442) 
0.5 
1.0 
2.0 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
<4.11 
<4.11 
<4.67 
<4.16 
<4.16 
<4.16 
>5.54 
>5.54 
>5.54 
II78 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY DECEMBER 2011 , VOL. 3 2 , NO. 12 
strain (ATCC 27853) of P. aeruginosa. Sagripanti et al24 sug-
gested that resistance to disinfectants may be more important 
than pathogenicity in determining the relative prominence of 
a organism as an agent responsible for hospital-acquired in-
fection. Species that more frequently survived exposure to 
germicidal agents were also the most commonly reported in 
association with hospital-acquired infection.24 
Although glutaraldehyde is the most commonly used 
chemical for reprocessing endoscopic equipment, our results 
suggest that it may not be the most effective product. P. 
aeruginosa, which is one of the most important hospital-
acquired pathogens, can become resistant, especially when 
there is not compliance with the recommended temperature 
and application time of disinfection. This new data may ex-
pedite the current trend to replace aldehydes with peracetic 
acid. Resistance to disinfectants and resistance to heat have 
emerged and can cause pseudo-outbreaks in healthcare 
settings. 
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